Admissible two-stage designs for phase II cancer clinical trials
Publication
, Conference
Jung, SH; Lee, T; Kim, KM; George, SL
Published in: CONTROLLED CLINICAL TRIALS
2003
Duke Scholars
Published In
CONTROLLED CLINICAL TRIALS
ISSN
0197-2456
Publication Date
2003
Volume
24
Start / End Page
61S / 61S
Related Subject Headings
- Public Health
- General Clinical Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jung, S. H., Lee, T., Kim, K. M., & George, S. L. (2003). Admissible two-stage designs for phase II cancer clinical trials. In CONTROLLED CLINICAL TRIALS (Vol. 24, pp. 61S-61S).
Jung, S. H., T. Lee, K. M. Kim, and S. L. George. “Admissible two-stage designs for phase II cancer clinical trials.” In CONTROLLED CLINICAL TRIALS, 24:61S-61S, 2003.
Jung SH, Lee T, Kim KM, George SL. Admissible two-stage designs for phase II cancer clinical trials. In: CONTROLLED CLINICAL TRIALS. 2003. p. 61S-61S.
Jung, S. H., et al. “Admissible two-stage designs for phase II cancer clinical trials.” CONTROLLED CLINICAL TRIALS, vol. 24, 2003, pp. 61S-61S.
Jung SH, Lee T, Kim KM, George SL. Admissible two-stage designs for phase II cancer clinical trials. CONTROLLED CLINICAL TRIALS. 2003. p. 61S-61S.
Published In
CONTROLLED CLINICAL TRIALS
ISSN
0197-2456
Publication Date
2003
Volume
24
Start / End Page
61S / 61S
Related Subject Headings
- Public Health
- General Clinical Medicine
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences